These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11345774)

  • 1. [Therapeutic strategy for leukemia: JALSG and the role of Japan in the 21st century].
    Ohno R
    Rinsho Ketsueki; 2001 Mar; 42(3):157-61. PubMed ID: 11345774
    [No Abstract]   [Full Text] [Related]  

  • 2. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party.
    Kataoka I; Kami M; Takahashi S; Kodera Y; Miyawaki S; Hirabayashi N; Okamoto S; Matsumoto N; Miyazaki Y; Morishita Y; Asai O; Maruta A; Yoshida T; Imamura M; Hamajima N; Matsuo K; Harada M; Mineishi S;
    Bone Marrow Transplant; 2004 Oct; 34(8):711-9. PubMed ID: 15361916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia.
    Aversa F; Reisner Y; Martelli MF
    Blood Cells Mol Dis; 2004; 33(3):294-302. PubMed ID: 15528148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Japan Adult Leukemia Study Group (JALSG)--twelve years of activities and future direction].
    Tomonaga M
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1133-8. PubMed ID: 10945007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role and cost efficacy of unrelated cord blood in adult hematopoietic stem transplantation.
    Cesaro S
    Bone Marrow Transplant; 2005 Aug; 36(3):275. PubMed ID: 15968283
    [No Abstract]   [Full Text] [Related]  

  • 7. Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program.
    Kato K; Kanda Y; Eto T; Muta T; Gondo H; Taniguchi S; Shibuya T; Utsunomiya A; Kawase T; Kato S; Morishima Y; Kodera Y; Harada M;
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):90-9. PubMed ID: 17222757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms.
    Suzuki R; Suzumiya J; Nakamura S; Kagami Y; Kameoka JI; Sakai C; Mukai H; Takenaka K; Yoshino T; Tsuzuki T; Sugimori H; Kawa K; Kodera Y; Oshimi K;
    Bone Marrow Transplant; 2006 Feb; 37(4):425-31. PubMed ID: 16400344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Allogeneic peripheral blood stem cell transplantation for high-risk leukemia].
    Huang X; Wang F; Guo N
    Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(22):1348-51. PubMed ID: 11930625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia].
    Sun J; Meng FY; Liu QF; Xu D; Xu B; Liu XL
    Ai Zheng; 2003 Dec; 22(12):1321-4. PubMed ID: 14693060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of acute myeloid leukemia--focusing on the data from JALSG studies].
    Miyawaki S
    Rinsho Ketsueki; 2008 Oct; 49(10):1386-93. PubMed ID: 18833923
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current status and issues in hematopoietic stem cell transplantation].
    Harada M
    Fukuoka Igaku Zasshi; 2007 Feb; 98(2):35-47. PubMed ID: 17396570
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparable antileukemia/lymphoma effects in nonremission patients undergoing allogeneic hematopoietic cell transplantation with a conventional cytoreductive or reduced-intensity regimen.
    Maruyama D; Fukuda T; Kato R; Yamasaki S; Usui E; Morita-Hoshi Y; Kim SW; Mori S; Heike Y; Makimoto A; Tajima K; Tanosaki R; Tobinai K; Takaue Y
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):932-41. PubMed ID: 17640597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Japanese College of Cardiology in the 20th century and hopes for the 21st century].
    Furuta S; Nakamura Y; Nimura Y; Omoto R; Sakamoto T; Tanaka M
    J Cardiol; 2001 Jan; 37(1):59-67. PubMed ID: 11200657
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hematopoietic stem cell transplantation in pediatric onco-hematology].
    Tamaro P; Barth E
    Recenti Prog Med; 2001 Apr; 92(4):278-82. PubMed ID: 11388047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Physiopathology and possible clinical use of hematopoietic stem cells. Recent advances].
    Testa U
    Recenti Prog Med; 2009 Mar; 100(3):144-55. PubMed ID: 19475843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent progress in the field of hematopoietic stem cell transplantation for leukemia].
    Kobayashi T; Akiyama H
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):351-6. PubMed ID: 19295257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment strategy for adult acute lymphoblastic leukemia].
    Okamoto S
    Rinsho Ketsueki; 2002 Jun; 43(6):427-32. PubMed ID: 12134694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.